Federal award (BPA CALL, fiscal year 2022)
Recipient: BOOZ ALLEN HAMILTON INC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-08-10 to 2024-02-14
Current total value of award: $1099979.78
Description: FIRM FIXED PRICE AWARD CENTER FOR DRUG EVALUATION (CDER) AND RESEARCH OFFICE OF NEW DRUGS - OFFICE OF THERAPEUTIC BIOLOGICS AND BIOSIMILARS (OTBB) BIOSIMILAR USER FEE ACT I PROGRAM  - BIOSIMILAR AND INTERCHANGEABLE PRODUCT EDUCATION, UPTAKE, AND IMP